WikiMD is world's largest health encyclopedia with
28,560 pages, 3,992,028 edits & 34,290,934 views.
90Y-Zevalin
(... ZEH-vuh-lin) A drug used with the drug rituximab to treat certain types of B-cell non-Hodgkin lymphoma. It is also being studied in the treatment of other types of B-cell tumors. 90Y-Zevalin contains a monoclonal antibody that binds to a protein called CD20, which is found on B cells. It also contains a radioactive substance called yttrium Y 90, which may help kill cancer cells. 90Y-Zevalin is a type of radioimmunoconjugate. Also called 90Y-ibritumomab tiuxetan, IDEC-Y2B8, and yttrium Y 90-ibritumomab tiuxetan.
Learn more about 90Y-Zevalin
Latest research (Pubmed)
External links
WikiMD needs you!
This WikiMD article 90Y-Zevalin is a stub.
If you are a healthcare professional familiar with the topic 90Y-Zevalin, or
A subject matter expert or authority on 90Y-Zevalin, you can help us.
About | Mission | Paid editors welcome!
| 90Y-Zevalin is part of WikiMD's Physician reviewed^ articles available 4free, 4all, 4ever! |
|---|
| Medicine: Health - Encyclopedia - Topics - Diseases - Cancer - Rare diseases - Random Page Navigation: Drugs - Wellness - Obesity - Diet - Ketogenic diet - W8MD weight loss diet - Editors: Recently Edited Pages - Alphabetical Order - Sponsors - USMLE The content on or accessible through WikiMD is for informational purposes only. WikiMD is not a substitute for professional medical advice. ^See full Disclaimers |
 Ad. Tired of being overweight?. W8MD's insurance Weight loss program can HELP* |
